Emory School

Concert Announces Clinical Advisory Board, New Medical Policies

Retrieved on: 
Wednesday, May 1, 2024
Cepheid variable, FDA, Biochemistry, Doctor of Philosophy, Cardiovascular disease, Vanderbilt University Medical Center, Associate, Palmetto, Prevalence, Concert, Global health, Congress, COVID, CRS, Food, Princeton University, Yale University, DRS, Duke University, Microbiology, Infection, Assistant, Molecular biology, Humana, Staphylococcus, Congressional Research Service, MD–PhD, Health, Library, Neuroscience, Research, Personalized medicine, Emory School, Public policy, Immunology, Medicine, Health policy, Maryland School, Government, Division, Rice University, University, Goucher College, Public health, MD, Duke, Staphylococcus aureus, Wake Forest University, Patient, Internal medicine

NASHVILLE, Tenn., May 1, 2024 /PRNewswire/ -- As part of its commitment to provide transparent, evidence-based medical policy and enable accurate reimbursement for a broader set of diagnostic services, Concert today announced the establishment of an advisory board of experts in clinical laboratory medicine and the release of policies for an expanded scope of routine and advanced laboratory testing.

Key Points: 
  • The newly formed board will advise Concert on its clinical laboratory content.
  • "Concert is working to align payers, providers, and labs to enable patient access to evidence-based testing," said Dr. Girish Putcha.
  • Following are brief bios on each member of the new clinical advisory board, in alphabetical order by last name.
  • Recent roles include Director of Laboratory Science at Palmetto's MolDX program, Chief Medical Officer and Clinical Laboratory Director of Freenome, and Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) member.

Philips, Emory School of Nursing and Partners Team up to Support Farm Worker Family Health Program and Clinic

Retrieved on: 
Tuesday, September 5, 2023
Nursing, Education, Health, Agriculture, Natural Resources, General Health, University, Blood pressure, Emory University, Emory School, Health Resources and Services Administration, AED (non-profit), Partnership, Health equity, Nurse education, School, Student, Brooks, H-2A, Work, Georgia Department of Public Health, Hearing, AEX, Faculty, RN, PHG, Nell Hodgson Woodruff School of Nursing, FAAN, BMI, Ellenton, MPH, NYSE, Community health, Doctor of Philosophy

Due to the nature of their work, access to and continuity of health care is a major challenge.

Key Points: 
  • Due to the nature of their work, access to and continuity of health care is a major challenge.
  • The program provides access to care for farmworkers and families in Colquitt, Tift, Brooks and Cook counties.
  • It also offers a faculty-led educational training and service-learning opportunity for Emory University undergraduate and graduate nursing students, in partnership with students from other health profession education programs across Georgia.
  • The Farm Worker Family Health Program, now in its 30th year, is organized by the Emory School of Nursing and held in partnership with the Georgia Ellenton Farmworker Health Clinic in Colquitt County and a host of state, local and educational partners.

Evidation Enables Rapid Recruitment and Enrollment for Veterans Heart Health Program

Retrieved on: 
Wednesday, March 1, 2023
Data Management, Technology, Professional Services, Health, General Health, Health Technology, Veterans, Health Insurance, Data Analytics, Software, Defense, American College, American College of Cardiology, Doctor of Philosophy, MD, National Heart Foundation of Australia, MBA, Heart rate, Assistant, Research, Use, United States Department of Veterans Affairs, Emory School, Heart Health Park, MPH, St. Cloud VA Health Care System, Woman, World Heart Federation, Medical device, Management, Veterans' affairs, Medicine, Cardiology, Veteran, Evidence Aid

In a real-world study, Use of a Virtual Patient Cohort as a Decentralized Approach for Rapid Enrollment into a National Heart Health Initiative: A Real-World Feasibility Study , the co-authors describe how Evidation’s digital health measurement and engagement platform rapidly recruited Veterans to participate in Heart Health on Evidation .

Key Points: 
  • In a real-world study, Use of a Virtual Patient Cohort as a Decentralized Approach for Rapid Enrollment into a National Heart Health Initiative: A Real-World Feasibility Study , the co-authors describe how Evidation’s digital health measurement and engagement platform rapidly recruited Veterans to participate in Heart Health on Evidation .
  • Heart Health is a cardiovascular educational and self-care program designed by Evidation and the American College of Cardiology.
  • Over 800 Veterans enrolled in Heart Health on Evidation in just 38 days.
  • In addition to enrolling more than 800 Veterans in the Heart Health program, Evidation engaged over 6,000 members who are also Veterans in a health survey conducted over an 8-week period.

Equify Health CEO Sylvie Leotin To Keynote American Society of Transplantation 2023 Summit

Retrieved on: 
Monday, February 20, 2023
Health, Hospital, Genentech, Emory School, Medicine, American Society of Transplantation, Patient, Research, Black, NASA, Health equity, Curriculum, AST, Society, Principal, Cancer, Pharmaceutical industry, Nursing, Oracle, Transplant

MENLO PARK, Calif., Feb. 20, 2023 /PRNewswire-PRWeb/ -- America's healthcare system continues to suffer from disparities in care and outcomes – with minority groups disproportionately affected. Equify Health Founder and CEO Sylvie Leotin will offer research-based insights and guidance to improve the patient experience and outcomes as the keynote speaker for the American Society of Transplantation's (AST) Cutting Edge of Transplantation (CEoT) summit on Feb 24, 2023, in Scottsdale, AZ. Leotin found the impetus for her mission from personal experiences when she fought for but did not always receive high-quality care for her cancer at one of the country's best hospitals. Her substantial experience as a design innovation expert and strategic consultant, advising venture-backed startup companies, also guided Leotin, who has been recognized as a Genentech healthcare innovation award winner.

Key Points: 
  • "The key to achieving health equity lies in improving patient experiences," says Sylvie Leotin, healthcare innovation pioneer and cancer survivor.
  • Equify Health Founder and CEO Sylvie Leotin will offer research-based insights and guidance to improve the patient experience and outcomes as the keynote speaker for the American Society of Transplantation's (AST) Cutting Edge of Transplantation (CEoT) summit on Feb 24, 2023, in Scottsdale, AZ.
  • "We're thrilled she will bring this expertise to our transplant community as the keynote speaker for our CEoT23 summit."
  • Before founding Equify Health, Leotin was CEO of Tech Atelier, a strategy consultancy advising innovative startup companies.

James E. Southerland, MD, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, January 31, 2023
Health, Physician, Biology, Mentorship, Emory School, Continental, Tragedy Assistance Program for Survivors, Atrium Health Floyd, Private practice, Family, Patient, Medical college, Parent, Hypertension, Medical degree, American Board of Commissioners for Foreign Missions, Paine College, American Academy, American Board of Family Medicine, Multimedia, Arthritis, Hospital, Nursing, Medicine, Family medicine, MD

GREENSBORO, Ga., Jan. 31, 2023 /PRNewswire/ -- James E. Southerland, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider for his contributions to the medical field.

Key Points: 
  • GREENSBORO, Ga., Jan. 31, 2023 /PRNewswire/ -- James E. Southerland, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider for his contributions to the medical field.
  • Dr. Southerland earned a Bachelor of Science degree in biology from Paine College in Augusta, GA in 1977.
  • He is board-certified in family medicine by the American Board of Family Medicine (ABFM).
  • Dr. Southerland is additionally grateful to his mentors, Bill H. Rhodes, MD; Lee Parker, MD; and David Thornton, MD.

Gaumard Scientific Announces First Installation of Robotic Patient Simulator with Conversational Speech, HAL® S5301, at Emory Nursing Learning Center

Retrieved on: 
Monday, November 14, 2022
Trauma, Nell Hodgson Woodruff School of Nursing, Movement, Technology, BSN, Media contacts database, Student, Emory School, Internet access, U.S. News & World Report, Industry, YouTube, Yonsei-KOICA Master's Degree Program, Emergency medical services, Education, Health, Government, Partnership, DNP, World, Intelligence, Feedback, Patient, Practitioner, Stroke, News, Georgetown University School of Nursing and Health Studies, AI, Engineering, School, No, Faculty, Doctor of Philosophy, Family, Emory, Leadership, HAL, Doctor of Nursing Practice, Certification, Speech, Emory Healthcare, ICU, CHSE, Research, Curriculum, Policy, Science, Public health, Medicine, Facebook, MD, Nursing

MIAMI and DECATUR, Ga., Oct. 14, 2022 /PRNewswire/ -- Gaumard Scientific Co., an industry leader in simulation technology for healthcare education and training, announced that HAL® S5301, the world's most advanced interdisciplinary patient simulator, has been installed at the Emory University Nell Hodgson Woodruff School of Nursing's new state-of-the-art simulation and learning center. This is the first commercial installation of HAL S5301, which has begun shipping to customers in the U.S.

Key Points: 
  • HAL S5301 is a permanent resident at the School of Nursing's Emory Nursing Learning Center , which opened to students this fall.
  • The center also offers immersive learning opportunities for licensed nurses through the Emory Nursing Experience , a partnership with Emory Healthcare .
  • "We are thrilled to announce the first installation of HAL S5301 at the Emory University Nell Hodgson Woodruff School of Nursing.
  • Our students will be even better prepared for nursing care and leadership roles because of their work with Emory HAL."

Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients

Retrieved on: 
Thursday, September 1, 2022
CA, COVID-19, CEO, Technology, Division, Research, SAN, Emory University, Doctor of Philosophy, Solution, Precision medicine, PACS, Physician, Area studies, SEC, Laboratory, XGN, Vista, Severe acute respiratory syndrome coronavirus 2, GLOBE, Medicare, Movement, Therapy, Twitter, Cell-bound complement activation products, Annual report, Private Securities Litigation Reform Act, COVID, Trial of the century, Patient, Emory School, Pharmaceutical industry, Nature, Lipotriches exagens, Rheumatology

Exagens clinical test offerings, run on samples from severe COVID-19 patients, helped researchers from Emory characterize the autoimmune profiles induced by SARS-CoV-2 infection.

Key Points: 
  • Exagens clinical test offerings, run on samples from severe COVID-19 patients, helped researchers from Emory characterize the autoimmune profiles induced by SARS-CoV-2 infection.
  • These efforts will assess the importance of long-term autoimmune monitoring in those patients experiencing lasting symptoms following acute pulmonary infection, including those caused by SARS-CoV-2.
  • Mathew Woodruff, PhD is a researcher at the Lowance Center for Human Immunology and the Division of Rheumatology at Emory School of Medicine.
  • We are excited to have partnered with Exagen on this important work investigating the origins of emerging self-targeted antibody responses in severe COVID-19.

James E. Southerland, MD is recognized by Continental Who's Who

Retrieved on: 
Monday, June 13, 2022
American Board of Family Medicine, Arthritis, Paine College, Emory School, Board of directors, Floyd Medical Center, Private practice, American Academy, Medical degree, Education, Multimedia, Physician, Health, Patient, Technology, Tragedy Assistance Program for Survivors, Director, Parent, Continental, Medical college, American Board of Commissioners for Foreign Missions, Family, View, American Family Physician, Hypertension, Mentorship, Hospital, Medicine, Biology, Medicine, MD, Family medicine

GREENSBORO, Ga., June 13, 2022 /PRNewswire/ -- James E. Southerland, MD, is being recognized by Continental Who's Who as a Top Family Physician in acknowledgment of his work at Lake Oconee Regional Primary & Urgent Care Center.

Key Points: 
  • GREENSBORO, Ga., June 13, 2022 /PRNewswire/ -- James E. Southerland, MD, is being recognized by Continental Who's Who as a Top Family Physician in acknowledgment of his work at Lake Oconee Regional Primary & Urgent Care Center.
  • As a practicing Family Physician for the past 34 years, James E. Southerland, MD, has treated countless patients in Augusta, GA, with various common and complex issues.
  • Dr. Southerland has worked in private practice and currently treats patients at Lake Oconee Regional Primary & Urgent Care Center.
  • Dr. Southerland is additionally grateful to his mentors, Bill H. Rhodes, MD; Lee Parker, MD; and David Thornton, MD.

CreditSights Hires Cisar as Global Head of Strategy

Retrieved on: 
Wednesday, September 15, 2021
Bloomberg Television, Health care, BNN, Emory School, International studies, Energy and Power, FINRA, Wells Fargo, High-yield debt, Emory College, Yahoo! Finance, CNBC, Human, GLOBE, Law, Illinois, Research, News, Bank

NEW YORK, N.Y., Sept. 15, 2021 (GLOBE NEWSWIRE) -- CreditSights, Inc., the independent voice of credit markets, announced the hiring of a new Global Head of Strategy, Winifred (Winnie) Cisar.

Key Points: 
  • NEW YORK, N.Y., Sept. 15, 2021 (GLOBE NEWSWIRE) -- CreditSights, Inc., the independent voice of credit markets, announced the hiring of a new Global Head of Strategy, Winifred (Winnie) Cisar.
  • We are excited to have Winnie join our team, as her expertise in the global credit markets provides a nice complement to our fundamental research offering, said Chris Ucko, Chris Ucko, Head of CreditSights and Lev Fin Intelligence.
  • Winnie most recently served as the Head of Credit Strategy and a Managing Director at Wells Fargo.
  • I am excited to be a part of the CreditSights team and contribute to the global growth and success of the company, said Winnie Cisar.

Curative Biotechnology, Inc. Announces Addition of Dr. Nicholas Boulis to Scientific and Clinical Advisory Board

Retrieved on: 
Thursday, September 2, 2021
Faculty, Research, Patient, OTC, Journal of Clinical Neuroscience, Journal, Neurology, Clinical, Review, Heart, Securities Act of 1933, Neuroprotection, Emory University School of Medicine, Philosophy, Harvard Medical School, CD56, Cleveland, Biological engineering, University of Michigan School of Kinesiology, Cleveland Clinic, Securities Exchange Act of 1934, Company, OTC Markets Group, Experimental Neurology, Emory School, Biology, University, Cell, Judgement, Deep brain stimulation, Michael, GLOBE, Coronavirus Scientific Advisory Board (Turkey), Disease, Gene, Yale University, Medical device

Boca Raton, FL, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT), announced today the addition of Dr. Nicholas Boulis, MD/PhD to the company's Scientific and Clinical Advisory Board. Dr. Boulis is on the faculty of the Emory School of Medicine in Atlanta and is the Director of Emory University's Gene and Cell Therapy for Neurorestoration Laboratory.

Key Points: 
  • Boca Raton, FL, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT), announced today the addition of Dr. Nicholas Boulis, MD/PhDto the company's Scientific and Clinical Advisory Board.
  • Dr. Boulis has been on the faculty at The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and at the University of Michigan School of Medicine.
  • Dr. Boulis serves on the Michael J Fox Foundation Advisory Committee on Deep Brain Stimulation Research.
  • Paul Michaels, Chairman and President of Curative Biotech, said, "We are extremely pleased with the addition of Dr. Boulis to the Clinical and Scientific Advisory Board.